Core Viewpoint - Vision Marine Technologies Inc. announced a public offering of 32,000,000 units at a price of $0.30 per unit, aiming to raise gross proceeds of $9,600,000 before expenses [1][2]. Group 1: Offering Details - Each unit consists of one common share (or a Pre-Funded Warrant) and one-half of one Warrant, with each whole Warrant allowing the purchase of one common share at an exercise price of $0.375 [1]. - The offering is expected to close on December 19, 2025, pending customary closing conditions [1]. - The common shares and Warrants will be issued separately, but must be purchased together in even numbers [1]. Group 2: Use of Proceeds - The proceeds from the offering will primarily be used for general corporate purposes, including inventory management, servicing floorplan lines of credit, general and administrative expenses, and prosecuting patent applications for the E-Motion™ electric powertrain technology [2]. Group 3: Company Overview - Vision Marine Technologies is a leader in high-voltage electric marine propulsion systems and operates a multi-brand boat retail and service platform [1][4]. - The company offers an integrated ecosystem that spans propulsion, retail, service, and on-water consumer engagement through its E-Motion™ propulsion platform and Nautical Ventures retail network [4].

Core Viewpoint - Actelis Networks, Inc. has announced a public offering of 6,250,000 shares of common stock at a price of $0.80 per share, aiming to raise approximately $5 million in gross proceeds for general corporate purposes [1][2]. Group 1: Offering Details - The public offering includes warrants to purchase an additional 6,250,000 shares of common stock, with an exercise price of $0.80 per share, exercisable upon issuance and expiring five years thereafter [1]. - The closing of the offering is expected around December 19, 2025, pending customary closing conditions [1]. Group 2: Financial Information - The gross proceeds from the offering are anticipated to be $5 million before deducting placement agent fees and other expenses [2]. - H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering [2]. Group 3: Company Overview - Actelis Networks, Inc. specializes in hybrid fiber and cyber-hardened networking solutions for IoT applications across various sectors, including government, military, and telecom [5]. - The company’s offerings provide fiber-grade performance while maintaining the flexibility and cost-efficiency of hybrid fiber-copper networks [5]. - Actelis also emphasizes network security through its "Cyber Aware Networking" initiative, which includes AI-based cyber monitoring and protection for edge devices [5].

Core Viewpoint - Lightwave Logic, Inc. is proposing to offer and sell its common stock in an underwritten public offering, aiming to leverage its proprietary electro-optic polymers for data transmission at higher speeds and lower power consumption [1] Company Summary - The company specializes in technology platforms that utilize proprietary electro-optic (EO) polymers [1] - The public offering will include a 30-day option for underwriters to purchase up to an additional 15% of the common stock to cover over-allotments [1]

Core Viewpoint - LightPath Technologies, Inc. has announced a public offering of 7,750,000 shares of its Class A common stock at a price of $7.75 per share, aiming for gross proceeds of approximately $60 million before expenses [1][2]. Group 1: Offering Details - The offering includes a 30-day option for underwriters to purchase an additional 1,162,500 shares at the public offering price [1]. - The offering is expected to close on or about December 15, 2025, pending customary closing conditions [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for working capital, investments, acquisitions, and general corporate purposes [2]. Group 3: Underwriters - Canaccord Genuity and Craig-Hallum are serving as joint bookrunners for the offering, with Lake Street acting as co-manager [2]. Group 4: Company Overview - LightPath Technologies is a leading provider of next-generation optics and imaging systems for defense and commercial applications, with a vertically integrated approach and in-house engineering design support [5]. - The company’s manufacturing facilities are located in Orlando, Florida, with additional sites in Texas, New Hampshire, Latvia, and China [5].

Core Points - Terns Pharmaceuticals, Inc. has successfully closed an underwritten public offering of 18,687,500 shares at a price of $40.00 per share, resulting in gross proceeds of $747.5 million before deductions [1][3] - The offering was managed by Jefferies, TD Cowen, and Leerink Partners as lead book-running managers, with Mizuho, Citizens Capital Markets, and Oppenheimer & Co. as co-managers [2] - The net proceeds from the offering will be utilized for research, clinical trials, development, and manufacturing of key product candidates, particularly TERN-701, as well as for working capital and general corporate purposes [3][5] Company Overview - Terns Pharmaceuticals is a clinical-stage oncology company focused on developing high-impact medicines, with its lead program TERN-701 being a selective allosteric BCR-ABL inhibitor aimed at improving treatment efficacy for chronic myeloid leukemia (CML) [5]

Core Viewpoint - Blink Charging Co. has announced a public offering of 26,666,666 shares at a price of $0.75 per share, aiming to raise approximately $20 million to fund capital expenditures and support working capital [1][3]. Group 1: Offering Details - The public offering is expected to close on or about December 12, 2025, pending customary closing conditions [1]. - H.C. Wainwright & Co. and Roth Capital Partners are the exclusive co-placement agents for the offering [2]. - The gross proceeds from the offering are anticipated to be around $20 million before deducting fees and expenses [3]. Group 2: Use of Proceeds - The net proceeds from the offering will primarily be used to expand the company's owned and operated DC Fast Charging network [3]. - Additional funds will support the company's working capital and general corporate requirements [3]. Group 3: Company Overview - Blink Charging Co. is a leader in electric vehicle charging equipment and services, facilitating the transition to electric transportation through innovative solutions [6]. - The company's offerings include EV charging networks, equipment, and services, utilizing proprietary cloud-based software for operation and maintenance [6]. - Blink Charging has established strategic partnerships for deploying charging solutions across various locations, including parking facilities, workplaces, and transportation hubs [6].

Company Overview - Top Wealth Group Holding Limited is a holding company incorporated in the Cayman Islands, with operations conducted through its subsidiary in Hong Kong, Top Wealth Group (International) Limited [6] - The company specializes in supplying premium-class sturgeon caviar and fine winery products, with its caviar products endorsed by CITES permits [6] - The brand "Imperial Cristal Caviar" has experienced significant sales growth since its market launch [6] Offering Details - The company announced the closing of a public offering of 720,000 units at a price of $7.00 per unit, which includes one Class A ordinary share and two types of warrants [1] - The total gross proceeds from this offering were approximately $5.04 million, before deducting fees and expenses [3] - If fully exercised, the Class A Warrants could provide an additional gross proceeds of approximately $10.08 million [3] Warrant Information - The Class A Warrants have an exercise price of $7.00 per share and are immediately exercisable upon issuance [1] - The Series A Class A Warrants will expire five years after the issuance date, while the Series B Class A Warrants will expire eighteen months after the issuance date [1] Placement Agent - Univest Securities, LLC acted as the exclusive placement agent for the offering [2] Regulatory Compliance - The securities were offered under a registration statement on Form F-1, which was filed with the SEC and declared effective on December 8, 2025 [4]

Core Viewpoint - Univest Securities, LLC has successfully closed a public offering for Top Wealth Group Holding Limited, raising approximately $5.04 million to support the company's operations in the premium caviar and fine winery products market [1][3]. Group 1: Offering Details - The offering consisted of 720,000 units, each unit comprising one Class A ordinary share and two types of warrants (Series A and Series B), priced at $7.00 per unit [2]. - The Class A warrants are immediately exercisable at an exercise price of $7.00 per share, with Series A warrants expiring five years after issuance and Series B warrants expiring eighteen months after issuance [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general corporate and working capital purposes [3]. Group 3: Company Overview - Top Wealth Group Holding Limited is a Cayman Islands-based holding company, primarily operating through its subsidiary in Hong Kong, specializing in premium-class sturgeon caviar and winery products [6]. - The company’s caviar products are endorsed with CITES permits and are marketed under private labels as well as its own brand, "Imperial Cristal Caviar," which has seen significant sales growth since its launch [6]. Group 4: Univest Securities Overview - Univest Securities, LLC is a full-service investment bank and securities broker-dealer, registered with FINRA since 1994, providing a range of financial services globally [7]. - The firm has raised over $1.7 billion in capital for various issuers since 2019 and has completed around 100 transactions across multiple industries [7].

Core Viewpoint - T1 Energy Inc. announced proposed public offerings totaling $260 million, consisting of $120 million in convertible senior notes and $140 million in common stock [1][3]. Group 1: Offering Details - The company plans to offer $120 million in convertible senior notes due 2030 and $140 million in common stock [1]. - Underwriters will have a 30-day option to purchase an additional $18 million in convertible notes and $21 million in common stock to cover over-allotments [2]. Group 2: Use of Proceeds - Net proceeds from the offerings will be used to comply with foreign entities of concern provisions, repay certain indebtedness, and for working capital and infrastructure related to the G2_Austin facility [3]. - The offerings are not contingent upon each other and are subject to market conditions [3]. Group 3: Company Background - T1 Energy Inc. is an energy solutions provider focused on building a U.S. supply chain for solar and batteries, having completed a transformative transaction in December 2024 [5]. - The company is positioned as a leading solar manufacturer in the U.S. and is exploring opportunities in Europe [5].

Core Viewpoint - Fulcrum Therapeutics, Inc. has announced a public offering of 11,851,853 shares of common stock priced at $13.50 per share, aiming to raise approximately $175 million in gross proceeds before expenses [1][2]. Group 1: Offering Details - The offering includes pre-funded warrants for certain investors to purchase up to 1,111,193 shares at a price of $13.499 per warrant, reflecting a slight discount from the common stock price [1]. - Fulcrum has granted underwriters a 30-day option to purchase an additional 1,944,456 shares under the same terms [1]. - The offering is expected to close around December 11, 2025, subject to customary closing conditions [3]. Group 2: Use of Proceeds - The net proceeds from the offering will primarily be used for general corporate purposes, including working capital, capital expenditures, and research and development expenses [2]. - Specific allocations may include funding clinical trials, regulatory submissions, commercialization efforts, and potential acquisitions or investments in complementary technologies or assets [2]. Group 3: Company Background - Fulcrum Therapeutics is focused on developing small molecules for patients with genetically defined rare diseases, with its lead program targeting sickle cell disease through the modulation of gene expression [7].